SCHEMBL7128428

SCHEMBL7128428

O=C(Nc1cccc2ccccc12)c1cccnc1NCc1ccncc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDR P35968 17/20 0.63
KDM4E B2RXH2 1/20 0.54
MAPT P10636 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
ABCB1 P08183 1/20 0.53
FLT1 P17948 2/20 0.52
RET P07949 1/20 0.51
MAP3K20 Q9NYL2 1/20 0.51
RIPK3 Q9Y572 1/20 0.51
ABL1 P00519 1/20 0.51
CSF1R P07333 1/20 0.51
IGF1R P08069 1/20 0.51
PDGFRB P09619 1/20 0.51
KIT P10721 1/20 0.51
FGFR1 P11362 1/20 0.51
FLT4 P35916 1/20 0.51
TEK Q02763 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL444751 0.99 KDR (0.62) KDRKDM4EMAPTSMN1; SMN2ABCB1
SCHEMBL4976797 0.87 KDR (0.63) KDRKDM4EMAPTSMN1; SMN2FLT1
SCHEMBL445500 0.83 KDR (0.57) KDRABCB1FLT1RETMAP3K20
SCHEMBL3151267 0.82 KDR (0.64) KDRKDM4E
SCHEMBL427761 0.82 KDR (0.58) KDRABCB1FLT1RETMAP3K20
Hydrochloric Acid SCHEMBL446993 0.81 KDR (0.57) KDRABCB1FLT1RETMAP3K20
SCHEMBL446392 0.81 KDR (0.66) KDRKDM4EABCB1FLT1RET
SCHEMBL7127183 0.81 KDR (0.74) KDRABCB1FLT1RETMAP3K20
Hydrochloric Acid SCHEMBL446959 0.80 KDR (0.73) KDRABCB1FLT1RETMAP3K20
SCHEMBL31362674 0.80 KDR (0.69) KDRKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1358184-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2003-11-05 EP disclosed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 WO disclosed